Page last updated: 2024-08-21

quinazolines and 4-butyrolactone

quinazolines has been researched along with 4-butyrolactone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jelínková, L; Kubelka, M1
Handel, MA; Sun, F1
Baek, JM; Boulbes, D; Esteva, FJ; Gomez-Cabello, D; Hawke, DH; Hortobagyi, GN; Hung, MC; Jin, Q; Lee, MH; Wang, YN; Yeung, SC; Yuan, LX1
Cufí, S; Del Barco, S; Martin-Castillo, B; Menendez, JA; Oliveras-Ferraros, C; Sauri-Nadal, T; Vazquez-Martin, A1
Bessadóttir, M; Eccles, S; Gowan, S; Ogmundsdóttir, HM; Ögmundsdóttir, S; Skúladóttir, EÁ1

Other Studies

5 other study(ies) available for quinazolines and 4-butyrolactone

ArticleYear
Neither Aurora B activity nor histone H3 phosphorylation is essential for chromosome condensation during meiotic maturation of porcine oocytes.
    Biology of reproduction, 2006, Volume: 74, Issue:5

    Topics: 4-Butyrolactone; Animals; Aurora Kinases; Benzamides; Chromosomes; Cycloheximide; Female; Histones; In Vitro Techniques; Meiosis; Oocytes; Phosphorylation; Protein Serine-Threonine Kinases; Quinazolines; Swine

2006
Regulation of the meiotic prophase I to metaphase I transition in mouse spermatocytes.
    Chromosoma, 2008, Volume: 117, Issue:5

    Topics: 4-Butyrolactone; Animals; Aurora Kinases; Benzamides; Cell Cycle Proteins; Chromosomal Proteins, Non-Histone; Cohesins; Cyclin-Dependent Kinases; Enzyme Inhibitors; Histones; Male; Meiotic Prophase I; Metaphase; Mice; Okadaic Acid; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Quinazolines; Spermatocytes

2008
Fatty acid synthase phosphorylation: a novel therapeutic target in HER2-overexpressing breast cancer cells.
    Breast cancer research : BCR, 2010, Volume: 12, Issue:6

    Topics: 4-Butyrolactone; Antineoplastic Agents; Apoptosis; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Fatty Acid Synthases; Female; Fluorescent Antibody Technique; Gene Expression; Humans; Lapatinib; Mass Spectrometry; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuregulin-1; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; RNA, Small Interfering; Signal Transduction

2010
Circulating fatty acid synthase: an exploratory biomarker to predict efficacy of the dual HER1/HER2 tyrosine kinase inhibitor lapatinib.
    Breast cancer research : BCR, 2011, Jan-24, Volume: 13, Issue:1

    Topics: 4-Butyrolactone; Antineoplastic Agents; Breast Neoplasms; Fatty Acid Synthases; Female; Humans; Quinazolines; Receptor, ErbB-2

2011
Effects of anti-proliferative lichen metabolite, protolichesterinic acid on fatty acid synthase, cell signalling and drug response in breast cancer cells.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2014, Oct-15, Volume: 21, Issue:12

    Topics: 4-Butyrolactone; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Fatty Acid Synthases; Female; Humans; Lapatinib; Lichens; Molecular Structure; Quinazolines; Receptor, ErbB-2; Signal Transduction

2014